Why the study?
To evaluate the effect of heart rate variability parameters recorded during acute STEMI on prognosis, as well as on laboratory and functional markers of heart failure.
Does sympathetic predominance based on heart rate variability in acute STEMI predict recurrent cardiovascular events and adverse heart failure marker profiles?
Cohort (n=199)
Does sympathetic predominance based on heart rate variability in acute STEMI predict recurrent cardiovascular events and adverse heart failure marker profiles?
Answers are grounded in this paper and cite their sources.
Enhanced sympathetic activity assessed by heart rate variability early after STEMI identifies patients at higher risk for recurrent cardiovascular events and persistent heart failure marker elevation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Dushina et al. (2019) conducted a cohort in Acute ST-segment elevation myocardial infarction (STEMI) (n=199). Sympathetic predominance (based on heart rate variability) vs. Balanced neurohumoral effects was evaluated on Recurrent cardiovascular events and deaths.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: